-
公开(公告)号:US20190030056A1
公开(公告)日:2019-01-31
申请号:US16071459
申请日:2017-01-23
申请人: THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORA , WASHINGTON UNIVERSITY IN ST. LOUIS
发明人: Cynthia DOWD , Audrey ODOM , Rachel Edwards , Robert BROTHERS
IPC分类号: A61K31/7056 , A61P33/06 , A61K31/122 , A61K31/137 , A61K31/357 , A61K31/366 , A61K31/437 , A61K31/4706 , A61K31/496 , A61K31/65
CPC分类号: A61K31/7056 , A61K31/122 , A61K31/137 , A61K31/155 , A61K31/357 , A61K31/366 , A61K31/437 , A61K31/4706 , A61K31/49 , A61K31/496 , A61K31/519 , A61K31/65 , A61K31/683 , A61K45/06 , A61P33/06 , Y02A50/411 , A61K2300/00
摘要: A pharmaceutical composition includes a small molecule and a pharmaceutically acceptable excipient. The small molecule interacts with a deoxyxylulose phosphate reductoisomerase (Dxr). A method for treating or preventing a microbial infection in a subject in need thereof includes administering the pharmaceutical composition. A method for inhibiting the growth of a eukaryotic pathogen includes contacting the eukaryotic pathogen with an effective amount of the pharmaceutical composition.